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ABSTRACT 
 
With upto 75% of all human disease being zoonotic in origin, proper study of the diseases is necessary to prevent 
any outbreak or human loss. More studies are required for developing countries like Nepal where there are no 
appropriate provisions for situations after breakouts. One such little known sporadic zoonosis is Q-fever. Q-fever 
(Coxiellosis) is caused by Gram-negative bacterium Coxiella burnetii that infect cattle and other ruminants with 
serious concerns for developing reproductive disorders and flu-like symptoms in human. There have been reports of 
undifferentiated febrile illness of Rickettsial cause in human and seroprevalence of Coxiella antibodies in goats of 
Chitwan and dairy cattle of Rupandehi for the first time. Low infectious dose and high resistivity to environment 
makes the disease more potent. Q-fever continues to be unexplored in Nepal despite its identification in neighboring 
countries like India. Thus, this paper after reviewing related articles from various journals, proceedings and 
magazines from online sources like Google Scholar, Mendeley, NCBI and PubMed is aimed to evaluate current 
status of disease, its epidemiology, zoonotic potential and preventive measures that can be adopted to minimize the 
threat of the disease as much as possible. 
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INTRODUCTION 
 
Q fever is an important zoonotic bacterial disease with great public health significance 
worldwide. Q fever (for query fever), is a zoonosis due to Coxiella burnetii, an obligate Gram-
negative, non-motile intracellular bacteria (Honarmand, 2012). The disease has been recognized 
since the 1930s and has global distribution, with the exception of the Antarctica and perhaps 
New Zealand (Hilbink et al, 1993), where its presence has not really been confirmed (Greenslade 
et al, 2003).  
 
The ‘Q’ stands for ‘query’, the name being given since the explanation of a 1935 outbreak of 
illness among abattoir workers in Australia was unknown. The microorganism of Q fever was 
discovered in 1937, once Frank Macfarlane Burnet and Mavis Freeman isolated the bacterium 
from one of Derrick’s patients (Burnet & Freeman, 1937). It was once firstly recognized as a 
species of Rickettsia by H.R. Cox and Gordon Davis from ticks in Montana, USA in 1938 (Davis 
& Cox, 1938). Q fever was first delineated by Edward Holbrook Derrick (Derrick, 1983) in 
abattoir workers in Brisbane, Queensland, Australia. Patients were presented with fever, 
headache and malaise. Serological tests for various possible etiologic agents were negative. Due 
to the unknown etiology, the term Q fever was so given for query (Maurin & Raoult, 1999). As 
is frequently in the nomenclature of microorganisms, there has been a collection of name for this 
agent. Initially, R. diaporica to R. burnetii and was later elevated to subgenus, Coxiella on the 
basis of cultural and biochemical characteristics. The agent is now known as Coxiella burnetii 
(Marrie, 1990). The name thus given is to honor two scientists; H.R. Cox and F.M. Burnet. 
 
The disease is a highly contagious zoonosis present in virtually all ‘animal kingdoms’, including 
arthropods; affects mostly humans, cattle, sheep and goats (Arricau-Bouvery & Rodolakis, 2005; 
EFSA, 2010; Lang, 1990; Maurin & Raoult, 1999). The foremost reservoir for the infective agent 
are domestic ruminants like cattle, sheep and goats while it can infect a large range of hosts such 
as mammals (humans, ruminants, small rodents, dogs and cats) and additionally birds, fish, 
reptiles and arthropods (Porter et al., 2011).  C. burnetii is extremely infectious, and solely few 
organisms can cause disease. It will stay viable and virulent for months due to its spore-like life 
cycle. (Honarmand, 2012). 
 
Humans typically get the infection through contaminated dust or by direct contact with infected 
animals or while aiding with the delivery of newborn animals, and infrequently by drinking 
contaminated milk or from tick bites. Affected persons develop high fever with headache, 
muscle pains, sore throat, nausea, vomition, chills, night sweats, fatigue, chest pains and stomach 
pains. In serious cases, it can lead to pneumonia and hepatitis. Q fever is an occupational hazard 
with farmers, veterinarians, abattoir workers, workers in dairy industry and laboratory personnel 
being at risk (Maurin et al., 1999). Despite Q fever being an OIE notifiable disease, it remains 
poorly reported and its surveillance is severely neglected (Porter et al., 2011). 
 
C. burnetii is taken into account as a weapon for bioterrorism, as the infectious dose of Coxiella 
burnetii is possibly one rickettsia and a single organism is sufficient to cause infection (Waag, 
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2007), with probability being approximately 0.9 (Jones et al.,  2006). The infectious particle is 
extremely resistant to environmental degradation. Because of its high infectivity and stability in 
the environment, C. burnetii is listed as a Category B biothreat agent.  (Waag D. M., 2007). 
According to Brooke et al. (2013), the dose for 50% infection (InfD50%) in human subjects is 
1.18 bacteria; dose for 50% illness (IllD50) in challenged humans is 5.58 bacteria. Also, the 
probability of a single viable C. burnetii causing infection in humans is 0.44 and for illness 0.12. 
 
METHODOLOGY 
 
In order to identify all published articles on Q fever, a systematic literature search was conducted 
in PubMed, NCBI, Mendeley, Google Scholar and NARC online library. Journals and thesis 
found in the library of IAAS was also taken for primary information. Searches were restricted to 
English language only. Keywords such as ‘Q fever’, ‘Coxiellosis’ and ‘Zoonosis’, their 
synonyms and closely associated words were used for the search. Also, references cited in the 
included studies were utilized for possible relevance.  
  
RESULTS AND DISCUSSION 
 
Etiological agent 
 
Q fever is caused by an obligate intracellular, small, Gram-negative coccobaillus bacterium 
Coxiella burnetii (0.2 to 0.4µm wide, 0.4 to 1µm long). Although possessing a membrane 
comparable to that of a gram-negative bacterium, it is typically not stainable by the Gram 
technique. Gimenez method is usually used to stain C. burnetii in clinical specimens or 
laboratory cultures (Eldin et al., 2017). Although classically viewed a rickettsial agent, recent 
phylogenetic analyses advocate that C. burnetii is more closely associated 
with Legionella and Francisella than to the genus Rickettsia. (Plummer, 2015). To date based on 
16S rRNA sequence analysis, the bacterium was reclassified from the order Rickettsiales to 
Legionellales and falls in the gamma group of Proteobacteria (Angelakis & Raoult, 2010).  
Unlike rickettsiae, C. burnetii produces a small, dense, highly resistant spore-like form that is 
highly stable in the environment (Gwida, 2012). It can survive for 7-10 months on walls at 15-
200C, for more than 1 month in cold storage and for more than 40 months in skim milk at room 
temperature (Angelakis & Raoult, 2010). The survivability has been attributed to the existence of 
C. burnetii developmental cycle variations; large-cell variants (LCV), small-cell variants (SCV) 
and small dense cells (SDC) (Coleman et al., 2004). SDC and SCV can likely survive 
extracellularly as infectious particles even in extreme environmental conditions (Gwida, 2012). 
LCVs are metabolically active cells that undergo differentiation to produce resistant spore-like 
forms, the small-cell variants. These are released when the cells lyse and can survive for long 
periods in the environment (Angelakis & Raoult, 2010).  
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Epidemiology 
 
Q-fever is established zoonotic disease worldwide listed in OIE Terrestrial Animal Health Code. 
Low infectious dose and ability of its spore to withstand harsh environmental conditions makes 
the disease present constantly around. The sickness was first reported in 1935 in abattoir workers  
 
in Brisbane, Australia as outbreak of febrile illness (Derrick, 1953). The disease is endemic, 
occurring in numerous geographic regions and climatic zones (Marrie, 1990).  
 
Host Distribution 
 
The epidemiology of C. burnetii is complex due to the fact that it has two major patterns of 
transmission. The organism circulates between wild animals and their ectoparasites, primarily 
ticks and alternative one occurs in domestic ruminants independent of wild animal cycle 
(Plummer, 2015). Cattle, sheep and goats are the most important reservoirs for human infections 
though it is found in a wide range of hosts. Horses, pigs, dogs, cats, camels and buffaloes and 
wild and domestic birds such as chickens, pigeons, ducks, geese and turkeys can be infected 
without showing any clinical signs (Acharya, 2015). Pets such as rabbits, dogs and cats have 
been known as potential source of urban outbreaks (Langley et al., 1988). 
 
Geographic Distribution 
 
Q fever has been described in the world all over except in New Zealand. There were 18 recorded 
outbreaks of Q fever from 12 different countries from 1999 to 2004 with 2 to 289 people 
involved (Arricau-Bouvery & Rodolakis, 2005).  
Incidence in the Netherlands: 
Q fever outbreak has been ongoing in The Netherlands since 2007 with the largest Q fever 
outbreak ever mentioned with more than 4000 reported cases and an rumored estimate of more 
than 40,000 total cases (Schneeberger et al., 2014). Q fever was made notifiable in The 
Netherlands in 1975 when it used to be very rare and new to other countries. The annual 
increment of cases were seen from 0 to 32 per year between 1975 and 2006 (Roest et al., 2011).  
Incidence in England and Wales: 
From 1975 to 1995, 67 to 169 Q fever cases were reportable yearly to the Communicable 
Disease Surveillance Center by laboratories in England and Wales (Maurin et al., 1999). 904 
cases of acute Q fever were reported in England and Wales between 2000 and 2015 that 
corresponds to mean annual incidence of 0.09 cases/100,000 populations/year without 
considering outbreak cases (Halsby et al., 2017).  
Incidence in Switzerland: 
Only 30 to 90 Q fever cases are reported annually to the Federal Office of Public Health in 
Switzerland (Maurin et al., 1999). In a large outbreak in 1983, 191 patients seen in the cases 
reported from the end of October to the beginning of December 1983 were serologically 
confirmed as acute Q fever by Complement Fixation and Indirect microimmunofloroscence test 
(Dupuis et al., 1987).  
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Incidence in USA: 
The prevalence of C. burnetii is poorly reviewed in United States. The first major Q fever 
outbreaks was reported in 1946 (Maurin et al., 1999). Q fever became notifiable disease in 
United States in 1999. The cases have increased from 21 cases per year (1978-1999) to 51 cases 
per year (2000-2004) (Hartzell et al., 2008). 
 
Incidence in Bhutan: 
15.2% of the patients presented with an undifferentiated febrile illness in 14 hospitals during the 
study period had evidence of concurrent rickettsial infection with maximum case of scrub typhus 
followed by Q fever (2.8%) (Tshokey et al., 2018). 
Incidence in India: 
In research conducted in India, the overall prevalence of Q fever in animals with history of 
reproductive disorder was seen to be 13.82%. The species-wise variation of prevalence of Q 
fever was observed to be 12.78% in cattle, 16.66% in buffaloes, 11.04% in sheep and 6.13% in 
goats (Vaidya et al., 2010). 
 
Transmission 
 
The most common mode of transmission of C. burnetii is through ticks (Angelakis & Raoult, 
2010). C. burnetii may infect around 40 species of ticks. Ticks are the reservoirs and vector of 
transmission to domestic mammals but not to humans (Chakrabarti, 2012). The organism is 
easily excreted in milk, urine, faeces and parturition products (amniotic fluid, placenta) of 
affected cattle, sheep, goats and other ungulates. Ingestion of contaminated products and 
inhalation of airborne contaminants are other ways of development of the disease. Close contact 
with the infected animals or with body fluids or secretions also results in the disease. Significant 
number of livestock handlers are proven to have antibodies against Q fever indicating exposure 
to the organism. Hence, Q fever is classified as occupational disease. 
 
Reservoirs 
 
Coxiella burnetii has wide range of reservoirs that encompass mammals, birds, and arthropods, 
mainly ticks. The common identified source of human contagion are farm animals such as cattle, 
goat and sheep. Although over 40 species of tick can be naturally infected with C. burnetii, they 
appear of no importance in maintenance of infections in livestock or humans(Maurin et al., 
1999). The organism multiplies in the gut cells of ticks and large numbers of C. burnetii are shed 
in tick faeces. In domestic ruminants, Q fever is mostly associated with abortions and dead or 
weak offspring. The infection is probably life-long or persisting for several years. Sheep, goats 
and cows are principally subclinical carriers, however can shed bacteria in their secretions and 
excreta.  
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Q Fever in animals 
 
Coxiella burnetii can infect wide range of animal species including farm animals (Gwida, 2012; 
Marrie, 1990). Infections in animals usually go unnoticed without developing any significant 
signs and symptoms. Reproductive failure is usually the only symptom presented when clinical 
disease occurs.C. burnetii are seen lodged in uterus and mammary glands of infected animals. 
The initial signs of the disease are anorexia and high rise of temperature. Abortion, stillbirth, 
premature delivery and delivery of weak offspring are commonly manifestation in ruminants 
(Angelakis& Raoult, 2010). Anorexia and abortions have been reported more frequently in sheep 
and goats (Gwida, 2012). Abortion occurs at later stage of pregnancy with no any apparent signs 
of abortion. The abortion rate ranges from 3 to 8%. Aborted females used to recover quickly but 
does not abort in the next gestation usually (Chakrabarti, 2012). On the basis of epidemiological 
data, dairy cows are more infected than sheep and goat which represent the vital source of human 
infection (Gwida, 2012).  
 
Significance and impact on public health 
 
Humans are the only species developing symptoms of the disease ranging from acute to chronic 
signs. Q fever is essentially air-borne disease with infection occurring after inhalation of 
contaminated aerosol. The infectious dose of Coxiella burnetii is possibly one rickettsia and the 
chance of a single organism initiating infection is approximately 0.9 (Jones et. al.,  2016). The 
primary attribute of Q fever in humans is its clinical polymorphism (Derrick, 1953). After 
incubation period of 1 to 3 weeks, the disease may progress to either acute or chronic phase.  
 
Acute Q fever 
 
50 to 60% of cases can be completely asymptomatic in the acute form or show illness associated 
with fever, fatigue, headache and myalgia (Porter et al., 2011). Acute Q fever has no typical 
form. The clinical signs vary in each patient but three main clinical presentations are- flu-like 
syndrome, pneumonia and hepatitis. The self-limited febrile illness with flu-like symptoms is 
characterized by a sudden onset of high-grade fever reaching 400C, severe headache, weight loss, 
myalgia and cough(Maurin et al., 1999).  
 
Atypical pneumonia is most commonly recognized form of acute Q fever. It is characterized by 
non-productive cough, fever and minimal auscultatory abnormalities but some patients are 
present with acute respiratory distress. Pleural effusions can be present but findings on the chest 
radiograph are nonspecific. (Honarmand, 2012). Acute Q fever is found primarily as a 
granulomatous hepatitis. However, in patients infected by aerosol route, Q fever is more 
common (Gwida, 2012). 
 
Cardiac involvement is seen in 2% of the acute Q fever cases where myocarditis is the leading 
cause of death. In the study, patients with valvular diseases who experience acute Q fever may 
remain asymptomatically infected. (Fenollar et al., 2002). Some other clinical manifestations are 
meningoencephalitis, lymphocytic meningitis, peripheral neuropathy, fatigue, rigors, night 
sweats, vomiting, pancreatitis and abortion.  
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Chronic Q fever 
 
According to Arricau-Bouvery and Rodolakis (2005) approximately 5% of acutely ill patients are 
reported have chronic form. It may develop many months to years after infection. The major 
manifestation of acute form is endocarditis. Incessant Q fever happens only in patients with 
inclining conditions incorporating those with heart valve sores, vascular anomalies and 
immunosuppression (Fenollar et al., 2002). The most common symptoms relate to heart and 
circulatory impairment due to endocarditis in 60-70% of cases. Other conditions associated with 
chronic Q fever embody osteoarticular infections and continual pulmonary infections. In addition 
to circulatory effects, chronic hepatitis is another common feature as is persistent fatigue 
syndrome (Wildman et al., 2002). 
 
Pregnant Women 
 
Both acute and chronic Q fever have been described during pregnancy. C. burnetii undergoes 
reactivation in the course of pregnancy and thus is accountable for higher rates of abortion, 
prematurity and low birth weight(Zeman et al., 1989). The risk is greater in the first trimester for 
pregnant women. In human, it has been isolated from the placenta of a woman who became 
pregnant 2 years after the episode of acute Q fever (Prasad et al., 1986), but few cases have been 
reported. Intrauterine transmission of C. burnetii has been pronounced but the consequences of 
congenital Q fever is yet to be determined (Honarmand, 2012). 
 
Scenario of Q-Fever in Nepal 
 
Undifferentiated febrile illnesses(UFIs) are a common clinical problem in south Asia (Chrispal et 
al., 2010). These are the fever barring a focus of infection on initial physical examination or in 
simple laboratory tests. In a study of UFIs in 627 patients from July 2008 to August 2011, 
serological evidence of Rickettsia was found to be 57% with one UFI case seropositive for Q 
fever (Thompson et al., 2015). Seropositivity in domestic animals have been recently detected in 
Nepal. The overall seroprevalence rate was found to be 1.45% (3.03% in sheep and 0% in goat) 
among 276 serum samples of goat and sheep in Bardiya and Surkhet district, Nepal (Koirala, 
2015), while 10% of 100 serum samples from goats with history of abortion and still births were 
seropositive in Chitwan district, Nepal (Acharya, 2015).This was the first instant of 
seropositivity of Coxiellosis detected in goats of Nepal (Acharya, 2015).In another study from 
October 2016 to December 2016, 1.63% of dairy cattle was reported to have circulating 
antibodies against C. burnetii in their blood (Panth et al., 2017). This was also Nepal’s first 
moment of seropositivity in cattle. 
 
The disease is new and yet unknown to many concerned authorities in Nepal. The government 
sector is all focused and prioritized on the prevalent zoonosis and economic disease like FMD, 
Brucellosis, Mastitis, etc. in the livestock sector at the moment. There is primary import of goats 
and other livestock from India associated with limited quarantine health assessment for Q fever. 
In such context, it is the next zoonotic disease waiting for the golden opportunity of breakout. 
Seroprevalence of the disease all over Nepal must be done within few years so that we can 
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determine the exact status of Q fever in Nepal. Once the disease status is known, the way 
forward can be planned accordingly. But there must be strict quarantine measures with 
assessment of Q fever as a must so that we can prevent the disease from entering the territory 
rather than to control after its emergence. 
 
Prevention and control 
 
Sanitary and prophylactic measures ought to be applied at herd and human level so as to 
minimize disease transmission at the time of Q fever outbreak. Measures to avoid exposure 
between human and persons at risk, animal and environmental contaminant should be followed. 
Regular cleaning and disinfection reduce the number of C. burnetii in the farm environment. 
 
Although vaccines for Q fever are developed, no vaccines have been permitted for use by the 
Food and Drug Administration(Hartzell et al., 2008). In field trials C. burnetii vaccines of 
inactivated whole cells (WC) in phase (ph) I as well as WC ph II vaccines prevented infections 
of cows exposed to naturally infected environments, provided they were vaccinated as non-
infected calves (Schmeer et. al., 1987). Q-Vax has been licensed for use in Australia, as part of a 
preventive vaccine program, highlighting an important success by effectively reducing the 
disease burden (Ruize & Wolfe, 2014). 
 
Finally, it is important to recollect that C. burnetii is extremely hazardous to humans and 
laboratory infections are frequent. Its low infectious dose, resistance in environment and aerosol 
route of transmission makes it fatal and protracted once after outbreak. C. burnetii is considered 
a potential agent of bioterrorism and is classified by the CDC as a group B agent. Live culture or 
contaminated material should be handled in proper facilities (Gwida, 2012). 
 
CONCLUSION 
 
There have already been reported cases of Q-fever in Nepal and many reports of undifferentiated 
febrile illness of Rickettsial nature. With positive seroprevalence in carriers and reports of 
outbreak in neighboring countries, Q-fever is next zoonosis looming over us that can strike at 
any instant. As we lack preparations for aftermath situations, we must have knowledge on 
prevention measure of the disease to limit its impact. The researches accomplished in Nepal have 
few sample sizes, so the validity and accuracy of this research could be challenged through 
increased sample sizes. Enhanced surveillance using confirmatory techniques with sufficient 
sample size is a prerequisite to confirm the findings. Further epizootiological investigations on Q 
fever in other farm animals and man at the country level is important to monitor and determine 
the magnitude of Q fever infection in order to estimate its economic impact on animal industry 
and its public health hazard.  
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